Cargando…
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34(+) Cells
SIMPLE SUMMARY: It has been well-demonstrated that EZH1/2 enzymes are involved not only in tumor development and progression, but also in the regulation of normal hematopoiesis from CD34(+)-HSPC. Given the crucial role of NK cells in tumor immune surveillance, in this study, we investigated whether...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830003/ https://www.ncbi.nlm.nih.gov/pubmed/33467134 http://dx.doi.org/10.3390/cancers13020319 |